These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7026970)

  • 1. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus.
    Robertson RP; Chen M
    J Clin Invest; 1977 Sep; 60(3):747-53. PubMed ID: 330566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
    Pfeifer MA; Halter JB; Graf R; Porte D
    Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of defective insulin responses to glucose, arginine, and beta-adrenergic stimulation in diabetics by sodium salicylate.
    McRae JR; Chen M; Robertson RP
    Adv Prostaglandin Thromboxane Res; 1980; 8():1287-9. PubMed ID: 6769309
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins.
    Giugliano D; Sgamboto S; Coppola L; Misso L; Torella R
    Prostaglandins Med; 1981 Jan; 6(1):41-50. PubMed ID: 6784135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release.
    Giugliano D; Di Pinto P; Ceriello A; Saccomanno F; Passariello N; D'Onofrio F
    Diabete Metab; 1985 Dec; 11(6):350-8. PubMed ID: 3936737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose infusion potentiates the acute insulin response to nonglucose stimuli during the infusion of somatostatin.
    Taborsky GJ; Smith PH; Halter JB; Porte D
    Endocrinology; 1979 Nov; 105(5):1215-20. PubMed ID: 488008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin synthesis inhibitors reverse alpha-adrenergic inhibition of acute insulin response to glucose.
    Metz SA; Robertson RP
    Am J Physiol; 1980 Dec; 239(6):E490-500. PubMed ID: 6255805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
    Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
    J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics.
    Krempf M; Ranganatan S; Ritz P; Garnier JM; Charbonnel B
    Eur J Clin Pharmacol; 1991; 41(5):411-5. PubMed ID: 1761067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: prostaglandins mediate defective glucose recognition in diabetes mellitus.
    Metz SA; McRae JR; Robertson RP
    Prostaglandins Med; 1980 Apr; 4(4):247-54. PubMed ID: 6994158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins, glucose homeostasis, and diabetes mellitus.
    Robertson RP
    Annu Rev Med; 1983; 34():1-12. PubMed ID: 6344749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation.
    Wajngot A; Alvarsson M; Glaser A; Efendic S; Luthman H; Grill V
    Diabetes; 1994 Dec; 43(12):1402-6. PubMed ID: 7958490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.